Active component of the drug "Lazolvan"is ambroxol hydrochloride - a substance with an expectorant effect. The intake of this drug enhances the separation of mucus in the bronchi and trachea and improves its excretion. Inflammation in the airways is weakened, the cough becomes moist and causes less discomfort to the patient.
Application mucolytic drug "Lazolvan"It is indicated for bronchitis, bronchial asthma (in the event that the sputum is difficult to withdraw), pneumonia. In bronchiectasis, when chronic inflammation occurs in altered bronchi, and in chronic obstructive pulmonary disease, when airflow in the respiratory tract is partially restricted, Lazolvan, as well as other drugs containing ambroxol, is one of the main medicines . It dilutes the bronchial secret and activates the motor activity of cilia - the outgrowths of the epithelium covering the inside of the bronchi. Cilia perform oscillatory movements, facilitating the purification of the bronchi from dust, which is thus exposed to the outside along with the mucus. In patients with chronic obstructive pulmonary disease, their function is reduced, so ambroxol or "Lazolvan" (tablets, injections or syrup) with this disease is indispensable.
Drugs based on ambroxol are also used fortreatment of newborns who have been diagnosed with a so-called respiratory distress syndrome-a severe respiratory disorder that develops more often in children who have developed as a result of caesarean section or preterm infants. This is due to the fact that normal alveoli of the lungs of a healthy person are covered with a special active substance - a surfactant, which prevents their decay. In premature babies it is not enough. Therefore, preparations based on ambroxol, stimulating the formation of surfactant, are widely used in this category of patients not only for treatment, but also for the prevention of respiratory distress syndrome.
The drug "Lazolvan" is produced in variousmedicinal forms. In severe diseases of the respiratory system, the injection solution Lazolvan is more often used. Tablets are given to adults, and also to children over the age of twelve. The adult daily dose is 90 mg ambroxol (3 tablets) at the onset of the disease, and 60 mg in subsequent days. The drug "Lazolvan" (tablets), the instruction for its use contains all the necessary information about its effects, can also be prescribed for children from six to twelve years - 15 mg (half-tablet), 2-3 times a day. There are also capsules of the same name - "Lazolvan Retard". They act for a longer time than the tablet form of the drug "Lazolvan". Tablets should be taken twice or thrice a day, while capsules containing 75 mg ambroxol are taken once a day.
Syrup "Lazolvan", in 5 mg of which contains 15ml ambroxol, is prescribed for children older than one year - twice a day (after two years - three times a day), half a teaspoon. Six-year-old child can be given already on a teaspoon of the drug, and twelve-year-old - two. There is also a syrup "Lazolvan" for adults: in its 5 ml contains 30 mg of ambroxol. It can be taken and children, starting with the age of six - based on the daily dose needed to treat the disease.
As for the contraindications for taking thismeans and side effects, they clearly describe the instructions attached to the drug "Lazolvan". Tablets should not be given to children under six years old - they should be replaced with syrup. Sometimes individual sensitivity to the drug is noted: it is manifested by allergic reactions (itching and rashes), headaches, nausea. Pregnant women can be appointed "Lazolvan", but only in the second and third trimesters. As for the lactation period, it is established that this drug penetrates into breast milk, but there is currently no information on its negative effect on the fetus.
Taking "Lazolvan" - tablets, syrup orcapsules, it is necessary to comply with all the prescriptions of the doctor, remembering the danger of overdose. Its first symptoms are nausea and vomiting, diarrhea. In this case, the drug is stopped and must be consulted by a doctor.
</ p>
